GSK163929
GSK163929 (compound 122) is an orally active, anti-HIV CCR5 antagonist with low inhibitory potency against hEGR. GSK163929 had no adverse effects in rats at 2000 mg/kg/day (i.v., 7 d) and in dogs at 250 mg/kg/day (i.v., 7 d) [1].
Product Specifications
CAS Number
716354-04-0
UNSPSC
12352005
Target
CCR; HIV
Type
Reference compound
Related Pathways
Anti-infection; GPCR/G Protein; Immunology/Inflammation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/gsk163929.html
Smiles
CC1=NC2=C(C=CC=C2)N1C3C[C@H](CC4)N([C@H]4C3)CCC5(C6=CC(F)=CC=C6)CCN(C(C7=CC(S(=O)(NC)=O)=C(F)C=C7Cl)=O)CC5
Molecular Formula
C36H40ClF2N5O3S
Molecular Weight
696.25
References & Citations
[1]Kazmierski WM, et al. Novel 4,4-disubstituted piperidine-based C-C chemokine receptor-5 inhibitors with high potency against human immunodeficiency virus-1 and an improved human ether-a-go-go related gene (hERG) profile. J Med Chem. 2011 Jun 9;54 (11) :3756-67.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC472853-100 1x 100 µL
CD54 / ICAM-1 (15.2), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC681786-500 1x 500 µL
P63 (Squamous, Basal and Myoepithelial Cell Marker) (TP63/1786), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC741132-100 1x 100 µL
CD45RB (PTPRC/1132), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC882408-500 1x 500 µL
CD14 (Monocyte / Macrophage Marker) (LPSR/2408), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC942961-500 1x 500 µL
C1QB / Complement C1q B-Chain (C1QB/2961), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details